IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,830 | -39.2% | 58,479 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $162,572 | +428.7% | 58,479 | +246.1% | 0.00% | – |
| Q1 2023 | $30,751 | -86.2% | 16,896 | -61.7% | 0.00% | -100.0% |
| Q4 2022 | $223,379 | +2.0% | 44,059 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $218,973 | +129.9% | 44,059 | +72.1% | 0.00% | +100.0% |
| Q2 2022 | $95,251 | -48.9% | 25,605 | -23.0% | 0.00% | 0.0% |
| Q1 2022 | $186,577 | +18.6% | 33,258 | +28.5% | 0.00% | 0.0% |
| Q4 2021 | $157,356 | -3.0% | 25,881 | +55.4% | 0.00% | -50.0% |
| Q3 2021 | $162,181 | -54.7% | 16,651 | -33.6% | 0.00% | -33.3% |
| Q2 2021 | $358,171 | +6.6% | 25,082 | +77.2% | 0.00% | 0.0% |
| Q1 2021 | $335,945 | – | 14,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |